Cargando…
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
BACKGROUND: Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid arthritis, has received much negative publicity for adverse events associated with its authorisation for emergency use to treat patients with COVID-19 pneumonia. We studied the safety of hydroxychloroquine, alone and...
Ejemplares similares
-
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
por: Lane, Jennifer C E, et al.
Publicado: (2020) -
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study
por: Burn, Edward, et al.
Publicado: (2020) -
Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe
por: Moreno-Martos, David, et al.
Publicado: (2023) -
Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study
por: Ostropolets, Anna, et al.
Publicado: (2022) -
Healthcare workers preparedness for COVID-19 pandemic in the occupied Palestinian territory: a cross-sectional survey
por: Alser, Osaid, et al.
Publicado: (2021)